Objective Erdheim‐Chester disease (ECD) is a rare form of non–Langerhans' cell histiocytosis
that may present with pulmonary involvement. We undertook the current study to evaluate …

Necrotizing autoimmune myopathy (NAM) is a group of acquired myopathies characterized
by prominent myofiber necrosis with little or no muscle inflammation. Recently, researchers …

Cancer can occur in patients with inflammatory myopathies. This association is mainly
observed in dermatomyositis, and myositis-specific antibodies have allowed us to delineate …

Early management of respiratory muscle failure using mechanical ventilation and high-dose
abatacept with CD86 receptor occupancy monitoring combined with ruxolitinib may be …

Histiocytoses are a group of heterogeneous diseases that mostly comprise Langerhans cell
histiocytosis (LCH) and non-LCH. The association of LCH with non-LCH is exceptional. We …

… Corinna Preusse, Helena Radbruch, Gillian Butler-Browne, Nicolas Champtiaux,
Kuberaka Mariampillai, Aude Rigolet, Peter Hufnagl, Norman Zerbe, Damien Amelin, Thierry …

Objective Immunosuppressive therapy may trigger hepatitis B virus (HBV) reactivation for
increased morbidity and mortality. We aimed to describe HBV reactivation in patients receiving …

Objective Among specific autoantibodies in DM, the anti–small ubiquitin-like modifier activating
enzyme (SAE) antibody is rare. We aim to describe the clinical characteristics, cancer …

Objective Anti-synthetase syndrome (anti-SS) is frequently associated with myositis and
interstitial lung disease (ILD). We evaluated prospectively, in a multicenter, open-label, phase II …

The anti-melanoma differentiation-associated gene 5 (MDA5) autoantibody is specifically
associated with dermatomyositis (DM). Nevertheless, anti–MDA5 + -patients experience …